content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Cesca Therapeutics, Inc (KOOL)
0.00
(0.00%)
content_middle
Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology.
Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.
Previous Close:
0.00
Open:
3.31
Bid:
3.35
Ask:
3.40
1yr Target Price:
2.00
Day's Range:
3.16 - 3.34
52wk Range:
0.00 - 0.00
Volume:
7977
Average Daily Volume:
92565
Market Capitalization:
0.00M
Trailing Annual Dividend Yield:
N/A
Shares Outstanding:
0.00M
content_right
- July 3, 2012 - 8:26am | Research Notes
- May 16, 2012 - 9:07am | Scoreboard at a Glance
- May 11, 2012 - 7:34am | Earnings
- April 23, 2012 - 7:33am
- April 11, 2012 - 9:06am
- February 10, 2012 - 9:42am
- January 31, 2012 - 9:05am
- January 10, 2012 - 2:57pm
- January 4, 2012 - 3:55pm
- November 11, 2011 - 1:57pm
- October 11, 2011 - 9:37am
- September 13, 2011 - 11:33am
- May 6, 2011 - 6:42am
- April 13, 2011 - 12:23pm
- March 30, 2011 - 11:00am
- March 5, 2011 - 12:00pm
- March 4, 2011 - 9:39am
- November 5, 2010 - 1:02pm
- November 5, 2010 - 7:28am
- October 20, 2010 - 11:47am